LightPath Technologies, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2022, compared with fiscal 2021. The request metadata says “2021 Q4,” but this filing reports fiscal 2022; the filing’s fourth quarter ended June 30, 2022.
Business context
LightPath designs and manufactures optical components and assemblies, including precision molded optics (PMO), infrared products, and specialty products. It operates manufacturing facilities in the United States, China, and Latvia. Its strategy is shifting from component sales toward customized optical engineered solutions and longer-term customer supply programs.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $35.56 million | $38.46 million |
| Gross margin | $11.81 million; 33% | $13.45 million; 35% |
| Operating loss | $2.63 million | $1.84 million |
| Net loss | $3.54 million; $0.13 per share | $3.19 million; $0.12 per share |
| Cash from operations | $1.46 million | $4.73 million |
| Capital expenditures | $1.63 million | $3.16 million |
- Revenue declined 8%. PMO revenue fell 5% to $15.02 million; infrared revenue fell 11% to $18.74 million; specialty revenue rose 12% to $1.80 million.
- Gross margin percentage declined mainly because lower revenue left some capacity underutilized, alongside inflation in raw-material costs and higher energy costs, particularly in Latvia. Riga infrared-coating costs also weighed on margins, though management said performance began improving in Q4.
- At June 30, 2022, cash and cash equivalents were $5.51 million and working capital was approximately $10.4 million. More than half of cash was held by foreign subsidiaries, and some Chinese cash is subject to repatriation restrictions.
- Loans payable totaled approximately $4.22 million, including a BankUnited term loan with a $3.9 million outstanding balance and an equipment loan. The term loan matures April 15, 2024; its rate was 4.25% at year-end and monthly payments were scheduled to rise to $100,000 beginning November 2022. Operating lease liabilities were approximately $10.44 million.
- Cash declined by $1.27 million during the year, including a $468,000 unfavorable foreign-exchange effect. The company reported EBITDA of $1.17 million, down from $1.47 million; EBITDA is a non-GAAP measure.
Material changes versus the prior year
- Revenue fell by $2.91 million, principally due to weaker industrial demand for BD6-based molded infrared products and reduced orders from a key Chinese telecommunications customer. Specialty-product and NRE revenue increased.
- Cash provided by operations decreased by $3.27 million, reflecting the larger loss, increased receivables, and lower accounts payable and accrued liabilities; inventory reductions partly offset these effects.
- Cash and cash equivalents fell from $6.77 million to $5.51 million. Total assets declined from $54.61 million to $50.71 million, and stockholders’ equity declined from $33.58 million to $29.73 million.
- Customer concentration eased: three customers represented 35% of revenue, versus 38% in FY2021. International sales were 61% of revenue, compared with 68%.
- Management reported total backlog of $17.77 million at June 30, 2022, down 17% from the prior year-end. Backlog can vary with the timing of annual and multiyear contract renewals.
Outlook, risks, and unusual items
- The filing provides no specific revenue or earnings guidance. Management expects sales growth over time, particularly from engineered solutions, and anticipates FY2023 capital expenditures at a similar level to FY2022, subject to opportunities and circumstances.
- In August 2022, the company announced a $4 million PMO supply agreement with a long-time European customer, expected to begin in the second half of FY2023 and run approximately 12–18 months.
- Management is pursuing refinancing before the BankUnited term loan’s April 2024 maturity; it cautions that refinancing is not assured. If unavailable, potential alternatives include equity or other financing, expense and capital-spending reductions, or strategic options. A $75.8 million shelf registration and $25.2 million ATM program were effective, but no ATM shares had been issued as of the filing.
- Following alleged misconduct by former managers at Chinese subsidiaries, the company incurred about $400,000 of related legal, consulting, and transition costs in FY2022. A $210,000 potential liability accrued in FY2021 was reversed in FY2022. Approximately $430,000 of disputed severance remained accrued; a Chinese labor court ruled in favor of former employees, and litigation continued. Management said the transition adversely affected domestic sales in China through FY2022.
- Key risks include recurring losses and accumulated deficit of approximately $203.8 million; customer concentration; exposure to China, international trade, and foreign-currency and cash-repatriation constraints; inflation and limited-source suppliers; and uncertainty from COVID-19 and the Russia–Ukraine conflict. No material legal proceeding outside the described China matters was reported.
- Management concluded disclosure controls and internal control over financial reporting were effective as of June 30, 2022. The independent auditor issued an unqualified opinion on the financial statements; it did not attest to internal-control effectiveness.
Important facts for investors to verify
- Whether operating performance, gross margins, and operating cash flow improve as revenue recovers and Riga coating capacity is qualified and utilized.
- Whether the company can refinance the BankUnited loan on acceptable terms before maturity, and how the higher scheduled payments and exit fees affect liquidity.
- Whether the $4 million customer agreement converts into shipments and revenue as expected, and how backlog develops after contract renewals.
- How the Chinese subsidiary litigation, remaining severance accrual, and customer-relationship rebuilding affect sales, costs, and cash needs.
- The availability and practical accessibility of foreign-held cash, and the potential for further customer concentration, supply-cost, or geopolitical pressures.